Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Running, not enrolling · Not applicable

Conditions studied: Cervical Cancer, Human Papillomavirus Infection

In brief

Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. This study is a supplement to increase representation of Asian and Asian American women in a pragmatic clinical trial that evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved minority women in a safety-net health system.

Key facts

Study ID

NCT06577220

Run by

Baylor College of Medicine

People needed

111

Starts

2023-09-28

Expected to finish

2026-01-24

Last updated by the study team

2025-10-14

Who can join

Age: 30 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Asian ethnicity reported in the electronic health record
• no history of hysterectomy or cervical cancer
• no Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years
• patient of Harris Health System in Harris County (Houston), Texas
• have at least 2 visits to ambulatory care within Harris Health System in the past 5 years
• be currently enrolled in a healthcare coverage or financial assistance plan accepted by Harris Health System or have been enrolled in a Harris Health coverage plan in the past 12 months

You may not qualify if…

• no valid telephone contact information
• unable to communicate in English, Vietnamese or Spanish
• currently pregnant
• history of cervical dysplasia in the past 3.5 years

Where it is running

• Harris Health System — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.